S. Luzi Fedeli

401 total citations
11 papers, 311 citations indexed

About

S. Luzi Fedeli is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, S. Luzi Fedeli has authored 11 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Hematology. Recurrent topics in S. Luzi Fedeli's work include Erythropoietin and Anemia Treatment (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Cancer Treatment and Pharmacology (3 papers). S. Luzi Fedeli is often cited by papers focused on Erythropoietin and Anemia Treatment (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Cancer Treatment and Pharmacology (3 papers). S. Luzi Fedeli collaborates with scholars based in Italy. S. Luzi Fedeli's co-authors include Anna Fedeli, Stefano Cascinu, Giuseppina Catalano, Elena Del Ferro, G. Catalano, Stefano Pieri, Alessandra Ravaioli, Anna Rossi, Donata Casadei Giunchi and Monica Indelli and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

S. Luzi Fedeli

11 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Luzi Fedeli Italy 6 176 123 63 43 39 11 311
Qilong Yi United States 11 95 0.5× 85 0.7× 77 1.2× 91 2.1× 23 0.6× 17 421
M Corral Spain 10 262 1.5× 152 1.2× 23 0.4× 34 0.8× 17 0.4× 12 436
T. Littlewood United Kingdom 4 179 1.0× 106 0.9× 34 0.5× 13 0.3× 29 0.7× 11 306
M. Lahousen Austria 10 74 0.4× 52 0.4× 51 0.8× 133 3.1× 18 0.5× 27 307
J O’Byrne Australia 6 471 2.7× 102 0.8× 60 1.0× 7 0.2× 24 0.6× 8 528
P Lutz France 8 99 0.6× 75 0.6× 46 0.7× 63 1.5× 6 0.2× 19 336
Ming‐Chih Chang Taiwan 11 151 0.9× 91 0.7× 71 1.1× 26 0.6× 12 0.3× 31 373
Cees Th.B.M. van Deursen Netherlands 12 276 1.6× 68 0.6× 94 1.5× 62 1.4× 50 1.3× 25 456
M. A. Hussein United States 10 198 1.1× 159 1.3× 10 0.2× 48 1.1× 9 0.2× 26 380
M. Cole‐Sinclair Australia 8 187 1.1× 90 0.7× 19 0.3× 17 0.4× 7 0.2× 13 339

Countries citing papers authored by S. Luzi Fedeli

Since Specialization
Citations

This map shows the geographic impact of S. Luzi Fedeli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Luzi Fedeli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Luzi Fedeli more than expected).

Fields of papers citing papers by S. Luzi Fedeli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Luzi Fedeli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Luzi Fedeli. The network helps show where S. Luzi Fedeli may publish in the future.

Co-authorship network of co-authors of S. Luzi Fedeli

This figure shows the co-authorship network connecting the top 25 collaborators of S. Luzi Fedeli. A scholar is included among the top collaborators of S. Luzi Fedeli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Luzi Fedeli. S. Luzi Fedeli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Montanari, Marco, Francesco� Fabbri, Giovanni Luca Frassineti, et al.. (2010). Phase II trial of nonpegylated liposomal doxorubicin and low-dose prednisone in second-line chemotherapy for hormone-refractory prostate cancer: A translational study.. Journal of Clinical Oncology. 28(15_suppl). 4683–4683. 3 indexed citations
2.
Pieri, Stefano, et al.. (2005). Lumbar sympathectomy under CT guidance: therapeutic option in critical limb ischaemia.. PubMed. 109(4). 430–7. 10 indexed citations
3.
Amadori, D., Annalisa Volpi, Oriana Nanni, et al.. (1997). Prospective use of tumor proliferative activity for adjuvant therapy in node-negative breast cancer patients. Cell Proliferation. 30. 1 indexed citations
4.
Cascinu, Stefano, Anna Fedeli, Elena Del Ferro, S. Luzi Fedeli, & Giuseppina Catalano. (1994). Recombinant human erythropoietin treatment in cisplatin-associated anemia: a randomized, double-blind trial with placebo.. Journal of Clinical Oncology. 12(5). 1058–1062. 155 indexed citations
5.
Cascinu, Stefano, Anna Fedeli, S. Luzi Fedeli, & Giuseppina Catalano. (1994). Cisplatin, 5-fluorouracil and interferon alpha 2b for recurrent or metastatic head and neck cancer. British Journal of Cancer. 69(2). 392–393. 10 indexed citations
6.
Cascinu, Stefano, et al.. (1994). CARBOPLATIN ASSOCIATED ANEMIA TREATED WITH SUBCUTANEOUS ERYTHROPOIETIN - A PILOT-STUDY. Oncology Reports. 1(1). 169–72. 4 indexed citations
7.
Cascinu, Stefano, Anna Fedeli, S. Luzi Fedeli, & G. Catalano. (1993). 5-Fluorouracil, leucovorin and interferon alpha 2b in advanced pancreatic cancer: A pilot study. Annals of Oncology. 4(1). 83–84. 28 indexed citations
8.
Cascinu, Stefano, Anna Fedeli, S. Luzi Fedeli, & Giuseppina Catalano. (1993). Cisplatin-associated anaemia treated with subcutaneous erythropoietin. A pilot study. British Journal of Cancer. 67(1). 156–158. 23 indexed citations
9.
Cascinu, Stefano, Anna Fedeli, S. Luzi Fedeli, & Giuseppina Catalano. (1993). Octreotide versus loperamide in the treatment of fluorouracil-induced diarrhea: a randomized trial.. Journal of Clinical Oncology. 11(1). 148–151. 68 indexed citations
10.
Cascinu, Stefano, Anna Fedeli, S. Luzi Fedeli, & Giuseppina Catalano. (1993). INTENSIVE WEEKLY CHEMOTHERAPY FOR ADVANCED GASTRIC-CANCER USING 5-FLUOROURACIL, CISPLATIN, EPI-DOXORUBICIN, 6S-LEUCOVORIN AND GRANULOCYTE-COLONY-STIMULATING FACTOR. International Journal of Oncology. 3(3). 535–8. 5 indexed citations
11.
Cascinu, Stefano, Anna Fedeli, S. Luzi Fedeli, & Giuseppina Catalano. (1992). Salvage Chemotherapy in Colorectal Cancer Patients with Good Peformance Status and Young Age after Failure of 5-Fluorouracil/Leucovorin Combination. Journal of Chemotherapy. 4(1). 46–49. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qilong Yi Breakdown of academic impact, for papers by M Corral Breakdown of academic impact, for papers by T. Littlewood Breakdown of academic impact, for papers by M. Lahousen Breakdown of academic impact, for papers by J O’Byrne Breakdown of academic impact, for papers by P Lutz Breakdown of academic impact, for papers by Ming‐Chih Chang Breakdown of academic impact, for papers by Cees Th.B.M. van Deursen Breakdown of academic impact, for papers by M. A. Hussein Breakdown of academic impact, for papers by M. Cole‐Sinclair
Rankless by CCL
2026